Racura Oncology Ltd (RAC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,061 | 5,213 | -1,283 | 30,978 | 12,790 |
| Common Stock Repurchased | N/A | -5 | N/A | -463 | -511 |
| Financing Cash Flow | $1,061 | $5,209 | $-1,283 | $30,514 | $12,280 |
| Exchange Rate Effect | -10 | 5 | -86 | -38 | 9 |
| Beginning Cash Position | 17,189 | 21,520 | 33,541 | 9,322 | 1,731 |
| End Cash Position | 13,666 | 17,189 | 21,520 | 33,541 | 9,322 |
| Net Cash Flow | $-3,513 | $-4,337 | $-11,934 | $24,257 | $7,582 |
| Free Cash Flow | |||||